Etoposide plus cisplatin, given alongside accelerated hyperfractionated thoracic radiotherapy (AHTRT), remains the gold standard regimen for patients with limited-stage small-cell lung cancer (SCLC), Japanese researchers say. The phase ...
Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Supplemental New Drug Application ...
Tags: Iroko Pharmaceuticals, FDA, ZORVOLEX, osteoarthritis pain
Boston Medical Center (BMC) successfully reduced audible alarms as a way to combat alarm fatigue and improve patient safety. The hospital, one of two in the country that spearheaded this issue, implemented a novel cost-effective approach ...
Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Supplemental New Drug Application ...
The U.S. Food and Drug Administration (FDA) is now accepting online submission of voluntary and mandatory dietary supplement adverse event reports. The FDA has implemented a secure capability in the interest of efficiency and as a ...
Tags: FDA, Dietary Supplement Adverse, secure capability, physician
According to newly published results from a survey of pharmacy directors, drug shortages remain a serious problem for patient safety. Nearly half of the responding directors reported adverse events at their facilities due to drug shortages, ...
Tags: drug shortages, patient care, adverse effects, patient outcomes
Findings of a preliminary study published in The Lancet Respiratory Medicine suggest that a patient's own bone-marrow stromal (stem) cells could be used to treat multidrug-resistant (MDR) and extensively-drug (XDR) tuberculosis (TB). ...
Tags: bone-marrow stromal cells, multidrug-resistant tuberculosis
The U.S. Food and Drug Administration today approved the first gel sealant for use in stopping fluid from leaking through the incision in a patient's cornea after cataract surgery with intraocular lens placement in adults. Prior to today's ...
Tags: Gel for Sealing Corneal Incision, First Gel After Cataract Surgery
It's the new year, a time when a smokers' thoughts often turn to quitting. Some people may use that promise of a fresh start to trade their tobacco cigarettes for an electronic cigarette, a device that attempts to mimic the look and feel ...
Tags: smokers, electronic cigarette, quit smoking
Amgen (NASDAQ: AMGN) and UCB (Euronext Brussels:UCB) today announced results from a Phase 2 trial evaluating romosozumab (AMG 785/CDP7851) in postmenopausal women with low bone mineral density (BMD). Published in the New England Journal of ...
Tags: Amgen, UCB, Phase 2 trial evaluating romosozumab, postmenopausal women
The drug inosine may be a safe and effective way to raise levels of urate -- a metabolism byproduct -- in patients with early Parkinson's, U.S. researchers say. Lead investigator Dr. Michael Schwarzschild of Massachusetts General Hospital ...
Among patients with idiopathic (of unknown cause) gastroparesis, use of the antidepressant nortriptyline compared with placebo for 15 weeks did not result in improvement in overall symptoms, according to a study appearing in the December 25 ...
Tags: idiopathic gastroparesis, antidepressant nortriptyline
Baxter International has submitted a biologics license application (BLA) to the US Food and Drug Administration (FDA) for the approval of a recombinant antihemophilic porcine sequence factor VIII called 'OBI-1' for the treatment of patients ...
Baxter International has filed an application to the US Food and Drug Administration (FDA) for a pediatric indication for Rixubis [Coagulation Factor IX (Recombinant)] to treat hemophilia B. The submission was based on a Phase II/III ...
Gilead Sciences has announced that the US Food and Drug Administration (FDA) has approved Sovaldi (sofosbuvir) 400mg tablets, a once-daily oral nucleotide analog polymerase inhibitor for the treatment of chronic hepatitis C (CHC) infection ...
Tags: Gilead Sciences, Chronic Hepatitis